Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zhenan Deng"'
Autor:
You Li, Zhenan Deng, Junjie Wen, Changxing Ou, Xiaomin Cen, Yongkang Liao, Qingling Zhang, Jiaxing Xie
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
AbstractObjective Dupilumab has been approved for the treatment of severe asthma with type 2 inflammation by inhibiting interleukin (IL)-4 and IL-13 signaling. However, dupilumab-induced hypereosinophilia (HE) has been reported and should not be igno
Externí odkaz:
https://doaj.org/article/9d34b8a72c1e4789958273d128319a93
Autor:
Qi Gao, Yuxin Lin, Ruqi Xu, Fan Luo, Ruixuan Chen, Pingping Li, Yuping Zhang, Jiao Liu, Zhenan Deng, Yanqin Li, Licong Su, Sheng Nie
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background Previous studies showed that the triglyceride-glucose (TyG) index was a better predictor of adverse cardiovascular events than triglycerides or fasting blood glucose alone. However, few studies have focused on new-onset hypertensi
Externí odkaz:
https://doaj.org/article/a0dda65b9bfa46a2ac4ac4df82810978
Autor:
Zhenan Deng, Meiling Jin, Changxing Ou, Wei Jiang, Jianping Zhao, Xiaoxia Liu, Shenghua Sun, Huaping Tang, Bei He, Shaoxi Cai, Ping Chen, Penghui Wu, Yujing Liu, Jian Kang, Yunhui Zhang, Mao Huang, Jinfu Xu, Kewu Huang, Qiang Li, Xiangyan Zhang, Xiuhua Fu, Changzheng Wang, Huahao Shen, Lei Zhu, Guochao Shi, Zhongmin Qiu, Zhongguang Wen, Xiaoyang Wei, Wei Gu, Chunhua Wei, Guangfa Wang, Lixin Xie, Jiangtao Lin, Yuling Tang, Zhihai Han, Kian Fan Chung, Qingling Zhang, Nanshan Zhong, on behalf of the C-BIOPRED Consortium, Lishao Guo
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 2, Pp 230-232 (2023)
Externí odkaz:
https://doaj.org/article/22f620387024415b81162c4235ecb4c5
Autor:
Zhenan Deng, Xuefei Zhang, Junjie Wen, Xiaojing Yang, Lingna Xue, Changxing Ou, Jianjuan Ma, Hongrui Zhan, Xiaomin Cen, Xuliang Cai, Yu Zhang, Riken Chen, Qingling Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Eosinophilic asthma is the predominant phenotype of asthma, and although these patients are sensitive to glucocorticoid therapy, they also experience many side effects. Lonicerin is a kind of bioflavonoid isolated from the Chinese herb Lonicera japon
Externí odkaz:
https://doaj.org/article/5e0b768a77ae48208b5337afb0e6b352
Autor:
Riken Chen, Huizhao Liao, Zhenan Deng, Zhenfeng He, Zhenzhen Zheng, Jianmin Lu, Mei Jiang, Xiaofeng Wu, Wenliang Guo, Zijie Huang, Huimin Chen, Cheng Hong, Nanshan Zhong
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveThis study seeks to evaluate the diagnostic value of computed tomography (CT) in pulmonary hypertension.MethodPubMed, Embase, Scopus, and Web of Science databases were searched to obtain the relevant English literature, and the retrieval tim
Externí odkaz:
https://doaj.org/article/101464c24f3d4ea4aa50f67f4adf0229
Autor:
Haojun Xie, Jie Liu, Yating Huo, Yuanxiong Cheng, Weiying Cheng, Yulin Liao, Meihong Zhang, Zhenan Deng
Publikováno v:
Journal of Cellular and Molecular Medicine
Accumulating evidence indicates that thrombin, the major effector of the coagulation cascade, plays an important role in the pathogenesis of asthma. Interestingly, dabigatran, a drug used in clinical anticoagulation, directly inhibits thrombin activi
Autor:
Zhenan Deng, Xuefei Zhang, Junjie Wen, Xiaojing Yang, Lingna Xue, Changxing Ou, Jianjuan Ma, Hongrui Zhan, Xiaomin Cen, Xuliang Cai, Yu Zhang, Riken Chen, Qingling Zhang
Publikováno v:
Frontiers in Pharmacology; 12/23/2022, Vol. 13, p1-14, 14p
Publikováno v:
Life sciences. 214
The YAP and TAZ, as the downstream effectors of Hippo pathway, have emerged as important translational co-activators of a wide variety of biological processes. YAP/TAZ plays a crucial role in the lung development and physiology. Dysregulation of YAP/